Sfoglia per AUTORE
PERRONE F
Collezione AOU Città della Salute di Torino
Items : 19
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2025 Mar 1;26(3):143-152. doi: 10.2459/JCM.0000000000001693. Epub 202
2025
AOU Città della Salute di Torino
Birtolo LI; Di Pietro G; D'Ascenzo F; Cuccuru G; Fabris E; Merlo M; Andreis A; Caforio ALP; Cameli M; Improta R; Campo G; De Ferrari GM; Emdin M; Galassi AR; Iliceto S; Imazio M; D'Agata Mottolese B; Porto I; Montisci R; Novo G; Pavan D; Vizza CD; Maestrini V; Basso C; Perrone Filardi P; Sinagra G; Mancone M;
Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 3;31(3):603-610. doi: 10.1158/1078-0432.CCR-24-2340.
2025
AOU Città della Salute di Torino
Colombo C; Hakkesteegt S; Le Cesne A; Barretta F; Blay JY; Grünhagen DJ; Penel N; Lam L; Fiore M; Palassini E; Grignani G; Tolomeo F; Collini P; Merlini A; Perrone F; Stacchiotti S; Verhoef C; Bonvalot S; Gronchi A;
Withdrawal notice to
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Caglio A; Arenare L; Tomassini L; Celant S; Iacovino ML; Di Maio M; Russo P; Perrone F;
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]. in ESMO open / ESMO Open. 2024 Nov;9(11):103693. doi: 10.1016/j.esmoop.2024.103693. Epub 2024 Oct 18.
2024
AOU Città della Salute di Torino
Arenare L; Di Liello R; De Placido P; Gridelli C; Morabito A; Pignata S; Nuzzo F; Avallone A; Maiello E; Gargiulo P; Schettino C; Gravina A; Gallo C; Chiodini P; Di Maio M; Perrone F; Piccirillo MC;
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials. in ESMO open / ESMO Open. 2024 Mar;9(3):102941. doi: 10.1016/j.esmoop.2024.102941. Epub 2024 Mar 6.
2024
AOU Città della Salute di Torino
Arenare L; Di Liello R; De Placido P; Gridelli C; Morabito A; Pignata S; Nuzzo F; Avallone A; Maiello E; Gargiulo P; Schettino C; Gravina A; Gallo C; Chiodini P; Di Maio M; Perrone F; Piccirillo MC;
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Apr 22;41:100912. doi: 10.1016/j.lanepe.2024.100912. eCollection 2024 Ju
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Russo P; Di Maio M; Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Sferrazza A; Piccirillo MC; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Arenare L; Caglio A; Tomassini L; Celant S; Iacovino ML; Perrone F;
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Jun 24;42:100973. doi: 10.1016/j.lanepe.2024.100973. eCollection 2024 Ju
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Cavanna L; Cinieri S; Blasi L; Pinto C; Domenico Beretta G; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Caglio A; Arenare L; Tomassini L; Celant S; Iacovino ML; Di Maio M; Russo P; Perrone F;
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 May 21;42:100940. doi: 10.1016/j.lanepe.2024.100940. eCollection 2024 Ju
2024
AO Ordine Mauriziano
AOU Città della Salute di Torino
Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Caglio A; Arenare L; Tomassini L; Celant S; Iacovino ML; Di Maio M; Russo P; Perrone F;
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab. in Journal for immunotherapy of cancer / J Immunother Cancer. 2024 Jan 30;12(1):e007823. doi: 10.1136/jitc-2023-007823.
2024
AOU Città della Salute di Torino
Serafini MS; Cavalieri S; Licitra L; Pistore F; Lenoci D; Canevari S; Airoldi M; Cossu Rocca M; Strojan P; Kuhar CG; Merlano M; Perrone F; Vingiani A; Denaro N; Perri F; Argiris A; Gurizzan C; Ghi MG; Cassano A; Allegrini G; Bossi P; De Cecco L;
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view. in Journal of endocrinological investigation / J Endocrinol Invest. 2024 Dec;47(12):2915-2928. doi: 10.1007/s40618-024-02417-z. Epub 2024 Jun 27.
2024
AOU Alessandria
AOU Città della Salute di Torino
Silvestris N; Aimaretti G; Perrone F; Candido R; Di Maio M; Tuveri E; Cortellini A; Sciacca L; Russo A; Morviducci L; Renzelli V; Monami M; Mazzilli R; Marino G; Ragni A; Gori S; Giuffrida D; Franchina T; Fogli S; D'Oronzo S; Argentiero A; Del Re M; Faggiano A; Zatelli MC; Gallo M; Avogaro A; Montagnani M; Marrano N; Natalicchio A; et alii...
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry. in European journal of heart failure / Eur J Heart Fail. 2024 Aug;26(8):1707-1714. doi: 10.1002/ejhf.3260. Epub 2024 Jun 23.
2024
AOU Città della Salute di Torino
AOU Novara
Metra M; Taddei S; Vizza D; Savarese G; Rosano G; Specchia C; Sinagra G; Senni M; Salzano A; Sciacqua A; Potena L; Piepoli MF; Perrone Filardi P; Patti G; Pedretti RFE; Palazzuoli A; Moschini L; Maccallini M; Masarone D; La Rovere MT; Leonardi S; Iacoviello M; Imazio M; Guazzi M; Fornaro A; Emdin M; De Ferrari GM; De Caterina R; Carugo S; et alii...
Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology. in ESMO open / ESMO Open. 2024 Aug;9(8):103654. doi: 10.1016/j.esmoop.2024.103654. Epub 2024 Jul 26.
2024
AOU Città della Salute di Torino
ASL Torino 4
Paratore C; Zichi C; Schiavone R; Caglio A; Gamba T; Bombaci S; Vellani G; Marandino L; Perrone F; Di Maio M;
Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago. in World journal of emergency surgery : WJES / World J Emerg Surg. 2024 Apr 16;19(1):14. doi: 10.1186/s13017-024-00543-w.
2024
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
Agnoletti V; Catena F; Baiocchi GL; Bravi F; Vallicelli C; Coccolini F; Sartelli M; Banchini F; Capelli P; Reames S; Cairl N; Biffl WL; Truong HP; Schaffer K; Curtiss W; McClure A; Austin TR; Hyman TS; Quick JA; Hemmila M; Napolitano LM; Sangji NF; Armento I; Egodage T; Coffua LS; Echeverria-Rosario K; Ratnasekera A; Seng SS; Bardes JM; et alii...
Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology. in International journal of cardiology / Int J Cardiol. 2024 Apr 1;400:131694. doi: 10.1016/j.ijcard.2023.131694. Epub 2023 Dec 30.
2024
AOU Città della Salute di Torino
Spaccarotella C; Montone RA; Fabris E; Moscarella E; Piccolo R; De Rosa S; Gragnano F; Calabrò P; Porto I; Di Marino M; Niccoli G; Zimarino M; D'Ascenzo F; Fraccaro C; Tarantini G; Saia F; Pelliccia F; Andò G; Indolfi C; Sinagra G; Perrone Filardi P;
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O(6)-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 May 10;40(14):1562-1573. doi: 10.1200/JCO.21.02583. Epub 2022 Mar 8.
2022
AO Ordine Mauriziano
AOU Città della Salute di Torino
Pietrantonio F; de Braud F; Milione M; Di Bartolomeo M; Di Maio M; Perrone F; Tamborini E; Brich S; Busico A; Conca E; Capone I; Marmorino F; Calegari MA; Cagnazzo C; Palazzo M; Zaniboni A; Ratti M; Bergamo F; Corti F; Niger M; Racca P; Prisciandaro M; Antonuzzo L; Pella N; Palermo F; Randon G; Murgioni S; Cremolini C; Lonardi S; et alii...
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 May 1;27(9):2505-2514. doi: 10.1158/1078-0432.CCR-20-4699. Epub 2021 Feb 5.
2021
AOU Città della Salute di Torino
Prisciandaro M; Tamborini E; Perrone F; Palermo F; Martinetti A; Sottotetti E; Randon G; Pagani F; Racca P; Sartore-Bianchi A; Murialdo R; Tomasello G; Smiroldo V; Clavarezza M; Procaccio L; Antoniotti C; Corti F; Lonardi S; Busico A; Manca P; Corallo S; Raimondi A; Di Bartolomeo M; Morano F; Pietrantonio F;
Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2019 Nov 20;37(33):3099-3110. doi: 10.1200/JCO.19.01254. Epub 2019 Sep 20.
2019
AOU Città della Salute di Torino
Morano F; Corallo S; Lonardi S; Raimondi A; Cremolini C; Rimassa L; Murialdo R; Zaniboni A; Sartore-Bianchi A; Tomasello G; Racca P; Clavarezza M; Adamo V; Perrone F; Gloghini A; Tamborini E; Busico A; Martinetti A; Palermo F; Loupakis F; Milione M; Fucà G; Di Bartolomeo M; de Braud F; Pietrantonio F;
Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 May;11(5):718-728. doi: 10.1016/j.jtho.2016.01.009. Epub 2016 Jan 22.
2016
AOU Città della Salute di Torino
Pelosi G; Gasparini P; Conte D; Fabbri A; Perrone F; Tamborini E; Pupa SM; Ciravolo V; Caserini R; Rossi G; Cavazza A; Papotti M; Nakatani Y; Maisonneuve P; Pastorino U; Sozzi G;
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28.
2014
AOU Città della Salute di Torino
Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; et alii...